These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17636348)

  • 1. Health care technology assessment and transfer.
    Boos N
    Eur Spine J; 2007 Aug; 16(8):1291-2. PubMed ID: 17636348
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in cost effectiveness analyses in orthopaedic surgery.
    Brauer CA; Neumann PJ; Rosen AB
    Clin Orthop Relat Res; 2007 Apr; 457():42-8. PubMed ID: 17242614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health technology assessment and economic evaluation across jurisdictions.
    Simoens S
    Value Health; 2010; 13(6):857-9. PubMed ID: 20701730
    [No Abstract]   [Full Text] [Related]  

  • 4. Revolution then evolution: the advance of health economic evaluation in Australia.
    Lopert R; Viney R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health-care costs and health technology assessment].
    Lettieri E; Masella C
    G Ital Nefrol; 2007; 24 Suppl 40():s22-36. PubMed ID: 18034409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHARMAC responds to Richard Milne on discounting health benefits and costs.
    Metcalfe S; Brougham M; Moodie P; Grocott R
    N Z Med J; 2005 Jul; 118(1219):U1600. PubMed ID: 16059415
    [No Abstract]   [Full Text] [Related]  

  • 7. Richard Milne responds to PHARMAC on discounting future health benefits and costs.
    Milne R
    N Z Med J; 2005 Aug; 118(1220):U1620. PubMed ID: 16132078
    [No Abstract]   [Full Text] [Related]  

  • 8. [More care for a limited budget; a case for a better use of the efficiency criteria].
    Rutten FF; Brouwer WB
    Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthopedic navigation: questions about long-term results and costs.
    Mathias JM
    OR Manager; 2007 Sep; 23(9):1, 15, 17. PubMed ID: 17960712
    [No Abstract]   [Full Text] [Related]  

  • 10. Healthcare technology and technology assessment.
    Herndon JH; Hwang R; Bozic KJ
    Eur Spine J; 2007 Aug; 16(8):1293-302. PubMed ID: 17426985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slowing the growth of health care costs--learning from international experience.
    Davis K
    N Engl J Med; 2008 Oct; 359(17):1751-5. PubMed ID: 18946060
    [No Abstract]   [Full Text] [Related]  

  • 12. Should future health-care costs be discounted? The case of diabetes in Australia.
    Scuffham PA
    Intern Med J; 2006 Mar; 36(3):148-9. PubMed ID: 16503948
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care technology.
    Robbins K
    State Health Care Am; 1994; ():63-6. PubMed ID: 10133853
    [No Abstract]   [Full Text] [Related]  

  • 14. Technology assessment in the German context.
    Drummond M
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S3. PubMed ID: 17619919
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost problems in an African country.
    de Sousa LA
    Acad Radiol; 1996 Apr; 3 Suppl 1():S126-7. PubMed ID: 8796539
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness and cost effectiveness of innovative medical techniques in public health].
    Stehr H
    Radiologe; 1996 Apr; 36(4):279-84. PubMed ID: 8677319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines in surgery: from the viewpoint of health care economics].
    Neubauer G
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():72-3. PubMed ID: 9574100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Has DRG solved the problem?].
    Oestmann A
    Praxis (Bern 1994); 2013 Feb; 102(4):183. PubMed ID: 23399600
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
    von der Schulenburg J; Vauth C; Mittendorf T; Greiner W
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.